BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33153494)

  • 1. EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression.
    Antin C; Tauziède-Espariat A; Debily MA; Castel D; Grill J; Pagès M; Ayrault O; Chrétien F; Gareton A; Andreiuolo F; Lechapt E; Varlet P
    Acta Neuropathol Commun; 2020 Nov; 8(1):183. PubMed ID: 33153494
    [No Abstract]   [Full Text] [Related]  

  • 2. EZHIP/CXorf67 mimics K27M mutated oncohistones and functions as an intrinsic inhibitor of PRC2 function in aggressive posterior fossa ependymoma.
    Hübner JM; Müller T; Papageorgiou DN; Mauermann M; Krijgsveld J; Russell RB; Ellison DW; Pfister SM; Pajtler KW; Kool M
    Neuro Oncol; 2019 Jul; 21(7):878-889. PubMed ID: 30923826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The diagnosis and prognosis of gliomas of the cerebral hemispheres after a study of 245 cases].
    Van Gehuchten P; Brucher JM; Cornelis G
    Acta Neurol Psychiatr Belg; 1967 Oct; 67(10):797-813. PubMed ID: 4295150
    [No Abstract]   [Full Text] [Related]  

  • 4. [Data towards the histochemical characteristics of brain tumors in rats].
    Abdullakhozhaeva MS; Dimant IN; Faĭn NG
    Arkh Patol; 1966; 28(5):69-71. PubMed ID: 4302618
    [No Abstract]   [Full Text] [Related]  

  • 5. Posterior fossa ependymoma H3 K27-mutant: an integrated radiological and histomolecular tumor analysis.
    Mariet C; Castel D; Grill J; Saffroy R; Dangouloff-Ros V; Boddaert N; Llamas-Guttierrez F; Chappé C; Puget S; Hasty L; Chrétien F; Métais A; Varlet P; Tauziède-Espariat A
    Acta Neuropathol Commun; 2022 Sep; 10(1):137. PubMed ID: 36104744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EZH2 inhibitory protein (EZHIP/Cxorf67) expression correlates strongly with H3K27me3 loss in posterior fossa ependymomas and is mutually exclusive with H3K27M mutations.
    Nambirajan A; Sharma A; Rajeshwari M; Boorgula MT; Doddamani R; Garg A; Suri V; Sarkar C; Sharma MC
    Brain Tumor Pathol; 2021 Jan; 38(1):30-40. PubMed ID: 33130928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On the diagnosis of gliomas].
    Müller W; Schröder R
    Neurochirurgia (Stuttg); 1968 Jan; 11(1):30-6. PubMed ID: 4297685
    [No Abstract]   [Full Text] [Related]  

  • 8. PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism.
    Jain SU; Do TJ; Lund PJ; Rashoff AQ; Diehl KL; Cieslik M; Bajic A; Juretic N; Deshmukh S; Venneti S; Muir TW; Garcia BA; Jabado N; Lewis PW
    Nat Commun; 2019 May; 10(1):2146. PubMed ID: 31086175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma.
    Michealraj KA; Kumar SA; Kim LJY; Cavalli FMG; Przelicki D; Wojcik JB; Delaidelli A; Bajic A; Saulnier O; MacLeod G; Vellanki RN; Vladoiu MC; Guilhamon P; Ong W; Lee JJY; Jiang Y; Holgado BL; Rasnitsyn A; Malik AA; Tsai R; Richman CM; Juraschka K; Haapasalo J; Wang EY; De Antonellis P; Suzuki H; Farooq H; Balin P; Kharas K; Van Ommeren R; Sirbu O; Rastan A; Krumholtz SL; Ly M; Ahmadi M; Deblois G; Srikanthan D; Luu B; Loukides J; Wu X; Garzia L; Ramaswamy V; Kanshin E; Sánchez-Osuna M; El-Hamamy I; Coutinho FJ; Prinos P; Singh S; Donovan LK; Daniels C; Schramek D; Tyers M; Weiss S; Stein LD; Lupien M; Wouters BG; Garcia BA; Arrowsmith CH; Sorensen PH; Angers S; Jabado N; Dirks PB; Mack SC; Agnihotri S; Rich JN; Taylor MD
    Cell; 2020 Jun; 181(6):1329-1345.e24. PubMed ID: 32445698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EZHIP: a new piece of the puzzle towards understanding pediatric posterior fossa ependymoma.
    Jenseit A; Camgöz A; Pfister SM; Kool M
    Acta Neuropathol; 2022 Jan; 143(1):1-13. PubMed ID: 34762160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
    Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
    Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of isocitrate dehydrogenase 1 mutation in 97 patients with glioma.
    Zhou YX; Wang JX; Feng M; Sun CM; Sun T; Chen GL; Du ZW
    J Mol Neurosci; 2012 Jul; 47(3):442-7. PubMed ID: 22113362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H3 K27M and EZHIP Impede H3K27-Methylation Spreading by Inhibiting Allosterically Stimulated PRC2.
    Jain SU; Rashoff AQ; Krabbenhoft SD; Hoelper D; Do TJ; Gibson TJ; Lundgren SM; Bondra ER; Deshmukh S; Harutyunyan AS; Juretic N; Jabado N; Harrison MM; Lewis PW
    Mol Cell; 2020 Nov; 80(4):726-735.e7. PubMed ID: 33049227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histochemical studies of functional groups of proteins in abnormal forms of glial cells. II. Glial tumors.
    Szydlowska H
    Acta Med Pol; 1970; 11(2):151-68. PubMed ID: 4316557
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intracerebral tumors in adulthood. 1: Intra-axial tumors].
    Grunwald I; Struffert T; Ghazzawie H; Möller V; Reith W
    Radiologe; 2002 Jul; 42(7):571-85; quiz 586-7. PubMed ID: 12242948
    [No Abstract]   [Full Text] [Related]  

  • 16. ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.
    Reuss DE; Sahm F; Schrimpf D; Wiestler B; Capper D; Koelsche C; Schweizer L; Korshunov A; Jones DT; Hovestadt V; Mittelbronn M; Schittenhelm J; Herold-Mende C; Unterberg A; Platten M; Weller M; Wick W; Pfister SM; von Deimling A
    Acta Neuropathol; 2015 Jan; 129(1):133-46. PubMed ID: 25427834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Various features of extrapyramidal pathology in tumors of the brain in children (clinico-morphologic study)].
    Chernetskii VK; Kantorovich VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(2):188-96. PubMed ID: 4306733
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas.
    Pajtler KW; Wen J; Sill M; Lin T; Orisme W; Tang B; Hübner JM; Ramaswamy V; Jia S; Dalton JD; Haupfear K; Rogers HA; Punchihewa C; Lee R; Easton J; Wu G; Ritzmann TA; Chapman R; Chavez L; Boop FA; Klimo P; Sabin ND; Ogg R; Mack SC; Freibaum BD; Kim HJ; Witt H; Jones DTW; Vo B; Gajjar A; Pounds S; Onar-Thomas A; Roussel MF; Zhang J; Taylor JP; Merchant TE; Grundy R; Tatevossian RG; Taylor MD; Pfister SM; Korshunov A; Kool M; Ellison DW
    Acta Neuropathol; 2018 Aug; 136(2):211-226. PubMed ID: 29909548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA profiles reveal three molecular subtypes in glioma.
    Li R; Qian J; Wang YY; Zhang JX; You YP
    CNS Neurosci Ther; 2014 Apr; 20(4):339-43. PubMed ID: 24393335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity and specificity of epithelial membrane antigen staining patterns in ependymomas.
    Hasselblatt M; Paulus W
    Acta Neuropathol; 2003 Oct; 106(4):385-8. PubMed ID: 12898159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.